DROXIDOPA Drug Patent Profile
✉ Email this page to a colleague
When do Droxidopa patents expire, and when can generic versions of Droxidopa launch?
Droxidopa is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Annora, Aurobindo Pharma Ltd, Bionpharma, Chartwell Rx, Hikma, Lupin Pharms, Msn Pharms Inc, Sciegen Pharms Inc, Somerset Theraps Llc, Sun Pharm, Teva Pharms Usa Inc, Upsher Smith Labs, Yampa, and Zydus Pharms. and is included in sixteen NDAs.
The generic ingredient in DROXIDOPA is droxidopa. There are six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the droxidopa profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Droxidopa
A generic version of DROXIDOPA was approved as droxidopa by AJANTA PHARMA LTD on February 18th, 2021.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DROXIDOPA?
- What are the global sales for DROXIDOPA?
- What is Average Wholesale Price for DROXIDOPA?
Summary for DROXIDOPA
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 16 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 95 |
| Clinical Trials: | 34 |
| Patent Applications: | 271 |
| Drug Prices: | Drug price information for DROXIDOPA |
| DailyMed Link: | DROXIDOPA at DailyMed |
Recent Clinical Trials for DROXIDOPA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kessler Foundation | Phase 4 |
| H. Lundbeck A/S | Phase 2 |
| Loma Linda University | Phase 2 |
Pharmacology for DROXIDOPA
| Physiological Effect | Increased Blood Pressure |
Medical Subject Heading (MeSH) Categories for DROXIDOPA
Anatomical Therapeutic Chemical (ATC) Classes for DROXIDOPA
US Patents and Regulatory Information for DROXIDOPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | DROXIDOPA | droxidopa | CAPSULE;ORAL | 213661-002 | Feb 18, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Somerset Theraps Llc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214543-002 | May 5, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Yampa | DROXIDOPA | droxidopa | CAPSULE;ORAL | 215265-003 | Nov 1, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sciegen Pharms Inc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214017-001 | Feb 18, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Somerset Theraps Llc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214543-003 | May 5, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sciegen Pharms Inc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214017-002 | Feb 18, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ajanta Pharma Ltd | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214391-001 | Feb 18, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
